Skip to main content
Top
Published in: BMC Public Health 1/2018

Open Access 01-12-2018 | Research article

Who seeks treatment for cannabis use? Registered characteristics and physical, psychological and psychosocial problem indicators among cannabis patients and matched controls

Authors: Solveig Glestad Christiansen, Anne Line Bretteville-Jensen

Published in: BMC Public Health | Issue 1/2018

Login to get access

Abstract

Background

There has been an absolute and relative increase in the number of patients with cannabis-related disorders as the principal diagnosis in many countries in recent years. Cannabis is now the most frequently mentioned problem drug reported by new patients in Europe, and cannabis patients constituted one third of all drug treatment patients in 2015. There is limited knowledge with regard to patient characteristics, the extent and types of health and psychosocial problems, as well as their association with long-term outcomes.

Methods

We analysed indicators of physical, psychological and psychosocial problems of all patients admitted to treatment for cannabis use in Norway in 2009 and 2010 using register data and observed them to the end of 2013. Patient characteristics and outcomes were compared to a randomly drawn control group with corresponding age and gender distribution. Using logistic regression of prospective data, we studied associations between baseline characteristics and work and study status in 2013.

Results

Cannabis patients tended to be relatively young and the large majority were male. They had parents who were less highly educated compared to controls, while there was no difference in migration background. In addition to an increased risk of premature death, nearly half of the patients received a secondary psychological diagnosis and a similar proportion received an additional substance use diagnosis during the 4–5 years of study follow-up. The cannabis patients were less educated than the control group and also less likely to be studying or working at the end of the study period. Entering treatment at a young age, having completed more than secondary education, having a highly-educated mother and not having a secondary diagnosis were factors that were positively associated with being in education or employment at the end of follow-up.

Conclusions

Data covering the entire Norwegian population of patients admitted primarily for cannabis-related problems showed comprehensive and complex patterns of physical, psychological and psychosocial problems. The prevalence and extent of these problems varied markedly from those of the general population. Work and study outcomes following treatment depended on the seriousness of the condition including co-morbidity as well as social capital.
Literature
1.
go back to reference EMCDDA. European Drug Report, European Monitoring Centre for Drugs and Drug Addiction, Lisbon. 2017. EMCDDA. European Drug Report, European Monitoring Centre for Drugs and Drug Addiction, Lisbon. 2017.
2.
go back to reference Hasin DS, Saha TD, Kerridge BT, Goldstein RB, Chou SP, Zhang H, et al. Prevalence of Marijuana Use Disorders in the United States Between 2001–2002 and 2012–2013. JAMA Psychiatry. 2015;72(12):1235–42. 10.1001/jamapsychiatry.2015.1858CrossRefPubMedPubMedCentral Hasin DS, Saha TD, Kerridge BT, Goldstein RB, Chou SP, Zhang H, et al. Prevalence of Marijuana Use Disorders in the United States Between 2001–2002 and 2012–2013. JAMA Psychiatry. 2015;72(12):1235–42. 10.1001/jamapsychiatry.2015.1858CrossRefPubMedPubMedCentral
3.
go back to reference Roxburgh A, Hall WD, Degenhardt L, McLaren J, Black E, Copeland J, Mattick RP. The epidemiology of cannabis use and cannabis-related harm in Australia 1993–2007. Addiction. 2010;105(6):1071–9.CrossRefPubMed Roxburgh A, Hall WD, Degenhardt L, McLaren J, Black E, Copeland J, Mattick RP. The epidemiology of cannabis use and cannabis-related harm in Australia 1993–2007. Addiction. 2010;105(6):1071–9.CrossRefPubMed
4.
go back to reference WHO. ATLAS on substance use (2010). In: resources for the prevention and treatment of substance use disorders. Geneva: World Health Organization; 2010. WHO. ATLAS on substance use (2010). In: resources for the prevention and treatment of substance use disorders. Geneva: World Health Organization; 2010.
5.
go back to reference Hall W. What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction. 2015;110(1):19–35.CrossRefPubMed Hall W. What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction. 2015;110(1):19–35.CrossRefPubMed
6.
go back to reference van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M. Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. Drug and Alcohol Dependence. 2013;133(2):352–9.CrossRefPubMed van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M. Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. Drug and Alcohol Dependence. 2013;133(2):352–9.CrossRefPubMed
7.
go back to reference WHO. The health and social effects of nonmedical cannabis use. Geneva: World Health Organization; 2016. WHO. The health and social effects of nonmedical cannabis use. Geneva: World Health Organization; 2016.
8.
go back to reference National Academies of Sciences, Engineering, and Medicine. The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. Washington, DC: The National Academies Press; 2017. https://doi.org/10.17226/24625.CrossRef National Academies of Sciences, Engineering, and Medicine. The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. Washington, DC: The National Academies Press; 2017. https://​doi.​org/​10.​17226/​24625.CrossRef
9.
go back to reference Khan SS, Secades-Villa R, Okuda M, Wang S, Pérez-Fuentes G, Kerridge BT, Blanco C. Gender differences in cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions. Drug Alcohol Depend. 2013;130(1):101–8.CrossRefPubMed Khan SS, Secades-Villa R, Okuda M, Wang S, Pérez-Fuentes G, Kerridge BT, Blanco C. Gender differences in cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions. Drug Alcohol Depend. 2013;130(1):101–8.CrossRefPubMed
10.
go back to reference Agosti V, Levin FR. Predictors of treatment contact among individuals with cannabis dependence. Am J Drug Alcohol Abuse. 2004;30(1):121–7.CrossRefPubMed Agosti V, Levin FR. Predictors of treatment contact among individuals with cannabis dependence. Am J Drug Alcohol Abuse. 2004;30(1):121–7.CrossRefPubMed
11.
go back to reference Stinson FS, Ruan WJ, Pickering R, Grant BF. Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. Psychological Med. 2006;36(10):1447–60.CrossRef Stinson FS, Ruan WJ, Pickering R, Grant BF. Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. Psychological Med. 2006;36(10):1447–60.CrossRef
12.
go back to reference EMCDDA. Treatment of cannabis-related disorders in Europe, Insights, European Monitoring Centre for Drugs and Drug Addiction. Lisbon: EMCDDA; 2015. EMCDDA. Treatment of cannabis-related disorders in Europe, Insights, European Monitoring Centre for Drugs and Drug Addiction. Lisbon: EMCDDA; 2015.
13.
go back to reference Wagner FA, Anthony JC. Male–female differences in the risk of progression from first use to dependence upon cannabis, cocaine, and alcohol. Drug Alcohol Depend. 2007;86(2):191–8.CrossRefPubMed Wagner FA, Anthony JC. Male–female differences in the risk of progression from first use to dependence upon cannabis, cocaine, and alcohol. Drug Alcohol Depend. 2007;86(2):191–8.CrossRefPubMed
14.
go back to reference EMCDDA. Perspectives on drugs: Characteristics of frequent and high-risk cannabis users, European Monitoring Centre for Drugs and Drug Addiction. Lisbon: EMCDDA; 2013. EMCDDA. Perspectives on drugs: Characteristics of frequent and high-risk cannabis users, European Monitoring Centre for Drugs and Drug Addiction. Lisbon: EMCDDA; 2013.
15.
go back to reference ESPAD. Results from the European School Survey Project on Alcohol and Other Drugs. Lisbon: EMCDDA; 2016. ESPAD. Results from the European School Survey Project on Alcohol and Other Drugs. Lisbon: EMCDDA; 2016.
16.
go back to reference Andreas JB, Bretteville-Jensen AL. Ready, willing, and able: The role of cannabis use opportunities in understanding adolescent cannabis use. Addiction. 2017;112(11):1973–82.CrossRef Andreas JB, Bretteville-Jensen AL. Ready, willing, and able: The role of cannabis use opportunities in understanding adolescent cannabis use. Addiction. 2017;112(11):1973–82.CrossRef
17.
go back to reference Vindenes V, Bramness J, Bretteville-Jensen AL, Mørland J, Bachs L. Fører sterkere cannabis til økt helserisiko? (Does more potent cannabis increase the health risk?). Legetidsskriftet. 2016;136:1736–8.CrossRef Vindenes V, Bramness J, Bretteville-Jensen AL, Mørland J, Bachs L. Fører sterkere cannabis til økt helserisiko? (Does more potent cannabis increase the health risk?). Legetidsskriftet. 2016;136:1736–8.CrossRef
18.
go back to reference WHO. International classification of diseases and related health problems, 10th revision. Geneva: World Health Organization; 1992. WHO. International classification of diseases and related health problems, 10th revision. Geneva: World Health Organization; 1992.
19.
go back to reference Urbanoski KA, Strike CJ, Rush BR. Individuals seeking treatment for cannabis-related problems in Ontario: demographic and treatment profile. Eur Addiction Res. 2005;11(3):115–23.CrossRef Urbanoski KA, Strike CJ, Rush BR. Individuals seeking treatment for cannabis-related problems in Ontario: demographic and treatment profile. Eur Addiction Res. 2005;11(3):115–23.CrossRef
20.
go back to reference Arendt M, Munk-Jørgensen P. Heavy cannabis users seeking treatment. Soc Psychiatry Psychiatr Epidemiol. 2004;39(2):97–105.CrossRefPubMed Arendt M, Munk-Jørgensen P. Heavy cannabis users seeking treatment. Soc Psychiatry Psychiatr Epidemiol. 2004;39(2):97–105.CrossRefPubMed
21.
go back to reference Strike CJ, Urbanoski KA, Rush BR. Who seeks treatment for cannabis-related problems? Can J Public Health. 2003;94(5):351–4.PubMed Strike CJ, Urbanoski KA, Rush BR. Who seeks treatment for cannabis-related problems? Can J Public Health. 2003;94(5):351–4.PubMed
22.
go back to reference Agosti V, Nunes E, Levin F. Rates of psychiatric comorbidity among US residents with lifetime cannabis dependence. Am J Drug Alcohol Abuse. 2002;28(4):643–52.CrossRefPubMed Agosti V, Nunes E, Levin F. Rates of psychiatric comorbidity among US residents with lifetime cannabis dependence. Am J Drug Alcohol Abuse. 2002;28(4):643–52.CrossRefPubMed
23.
go back to reference Papzakinc ZE, Connor JP, Feeney GF, Young RM, Gullo MJ. Treatment seeking in cannabis dependence: The role of social cognition. Drug Alcohol Depend. 2017;170:142–6.CrossRef Papzakinc ZE, Connor JP, Feeney GF, Young RM, Gullo MJ. Treatment seeking in cannabis dependence: The role of social cognition. Drug Alcohol Depend. 2017;170:142–6.CrossRef
24.
go back to reference Legleye S, Janssen E, Beck F, Chau N, Khlat M. Social gradient in initiation and transition to daily use of tobacco and cannabis during adolescence: a retrospective cohort study. Addiction. 2011;106(8):1520–31.CrossRefPubMed Legleye S, Janssen E, Beck F, Chau N, Khlat M. Social gradient in initiation and transition to daily use of tobacco and cannabis during adolescence: a retrospective cohort study. Addiction. 2011;106(8):1520–31.CrossRefPubMed
25.
go back to reference Colpaert K, Vanderplasschen W, Van Hal G, Schuyten G, Broekaert E. Cannabis-Related treatment demands in Belgium: a socio-demographic and treatment seeking profile. Arch Public Health. 2010;67(4):179.CrossRefPubMedCentral Colpaert K, Vanderplasschen W, Van Hal G, Schuyten G, Broekaert E. Cannabis-Related treatment demands in Belgium: a socio-demographic and treatment seeking profile. Arch Public Health. 2010;67(4):179.CrossRefPubMedCentral
26.
27.
go back to reference Janowsky DS, Clopton PL, Leichner PP, Abrams AA, Judd LL, Pechnick R. Interpersonal effects of marijuana: a model for the study of interpersonal psychopharmacology. Arch General Psychiatry. 1979;36(7):781–5.CrossRef Janowsky DS, Clopton PL, Leichner PP, Abrams AA, Judd LL, Pechnick R. Interpersonal effects of marijuana: a model for the study of interpersonal psychopharmacology. Arch General Psychiatry. 1979;36(7):781–5.CrossRef
28.
go back to reference Kaestner R. The effects of cocaine and marijuana use on marriage and marital stability. J Fam Issues. 1997;18(2):145–73.CrossRef Kaestner R. The effects of cocaine and marijuana use on marriage and marital stability. J Fam Issues. 1997;18(2):145–73.CrossRef
29.
go back to reference Hamilton HA, Danielson AM, Mann RE, Paglia-Boak A. The roles of family, peer, school, and attitudinal factors in cannabis use across immigrant generations of youth. J Drug Issues. 2012;42:46–58.CrossRef Hamilton HA, Danielson AM, Mann RE, Paglia-Boak A. The roles of family, peer, school, and attitudinal factors in cannabis use across immigrant generations of youth. J Drug Issues. 2012;42:46–58.CrossRef
30.
go back to reference Sarasa-Renedo A, Sordo L, Pulido J, Guitart A, González-González R, Hoyos J, et al. Effect of immigration background and country-of-origin contextual factors on adolescent substance use in Spain. Drug Alcohol Depend. 2015;153:124–34.CrossRefPubMed Sarasa-Renedo A, Sordo L, Pulido J, Guitart A, González-González R, Hoyos J, et al. Effect of immigration background and country-of-origin contextual factors on adolescent substance use in Spain. Drug Alcohol Depend. 2015;153:124–34.CrossRefPubMed
31.
go back to reference Sordo L, Indave BI, Vallejo F, Belza MJ, Sanz-Barbero B, Rosales-Statkus M, Barrio G. Effect of country-of-origin contextual factors and length of stay on immigrants’ substance use in Spain. Eur J Public Health. 2015;25(6):ckv144. Sordo L, Indave BI, Vallejo F, Belza MJ, Sanz-Barbero B, Rosales-Statkus M, Barrio G. Effect of country-of-origin contextual factors and length of stay on immigrants’ substance use in Spain. Eur J Public Health. 2015;25(6):ckv144.
32.
go back to reference Rodham K, Hawton K, Evans E, Weatherall R. Ethnic and gender differences in drinking, smoking and drug taking among adolescents in England: a self-report school-based survey of 15 and 16-year olds. J Adolescence. 2005;28(1):63–73.CrossRef Rodham K, Hawton K, Evans E, Weatherall R. Ethnic and gender differences in drinking, smoking and drug taking among adolescents in England: a self-report school-based survey of 15 and 16-year olds. J Adolescence. 2005;28(1):63–73.CrossRef
33.
go back to reference Svensson M, Hagquist C. Adolescent alcohol and illicit drug use among first-and second-generation immigrants in Sweden. Scand J Soc Med. 2010;38(2):184–91. Svensson M, Hagquist C. Adolescent alcohol and illicit drug use among first-and second-generation immigrants in Sweden. Scand J Soc Med. 2010;38(2):184–91.
34.
go back to reference Legleye S, Beck F, Khlat M, Peretti-Watel P, Chau N. The influence of socioeconomic status on cannabis use among French adolescents. J Adolescent Health. 2012;50(4):395–402.CrossRef Legleye S, Beck F, Khlat M, Peretti-Watel P, Chau N. The influence of socioeconomic status on cannabis use among French adolescents. J Adolescent Health. 2012;50(4):395–402.CrossRef
35.
go back to reference Chen CY, O’Brien MS, Anthony JC. Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001. Drug Alcohol Depend. 2005;79(1):11–22.CrossRefPubMed Chen CY, O’Brien MS, Anthony JC. Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001. Drug Alcohol Depend. 2005;79(1):11–22.CrossRefPubMed
36.
go back to reference Degenhardt L, Hall W, Lynskey M. Exploring the association between cannabis use and depression. Addiction. 2003;98(11):1493–504.CrossRefPubMed Degenhardt L, Hall W, Lynskey M. Exploring the association between cannabis use and depression. Addiction. 2003;98(11):1493–504.CrossRefPubMed
37.
go back to reference Imtiaz S, Shield KD, Roerecke M, Cheng J, Popova S, Kurdyak P, et al. The burden of disease attributable to cannabis use in Canada in 2012. Addiction. 2016;111(4):653–62.CrossRefPubMed Imtiaz S, Shield KD, Roerecke M, Cheng J, Popova S, Kurdyak P, et al. The burden of disease attributable to cannabis use in Canada in 2012. Addiction. 2016;111(4):653–62.CrossRefPubMed
38.
go back to reference Arendt M, Munk-Jørgensen P, Sher L, Jensen SOW. Mortality following treatment for cannabis use disorders: predictors and causes. J Subst Abus Treat. 2013;44(4):400–6.CrossRef Arendt M, Munk-Jørgensen P, Sher L, Jensen SOW. Mortality following treatment for cannabis use disorders: predictors and causes. J Subst Abus Treat. 2013;44(4):400–6.CrossRef
39.
go back to reference Stephens RS, Roffman RA, Simpson EE. Adult marijuana users seeking treatment. J Consulting Clin Psychol. 1993;61(6):1100.CrossRef Stephens RS, Roffman RA, Simpson EE. Adult marijuana users seeking treatment. J Consulting Clin Psychol. 1993;61(6):1100.CrossRef
40.
go back to reference Degenhardt L, Whiteford HA, Ferrari AJ, Baxter AJ, Charlson FJ, et al. The global burden of disease attributable to illicit drug use: results from the GBD 2010 study. Lancet. 2013;382(9904):1564–74.CrossRefPubMed Degenhardt L, Whiteford HA, Ferrari AJ, Baxter AJ, Charlson FJ, et al. The global burden of disease attributable to illicit drug use: results from the GBD 2010 study. Lancet. 2013;382(9904):1564–74.CrossRefPubMed
41.
go back to reference Buckner JD, Bonn-Miller MO, Zvolensky MJ, Schmidt NB. Marijuana use motives and social anxiety among marijuana-using young adults. Addict Behav. 2007;32(10):2238–52.CrossRefPubMedPubMedCentral Buckner JD, Bonn-Miller MO, Zvolensky MJ, Schmidt NB. Marijuana use motives and social anxiety among marijuana-using young adults. Addict Behav. 2007;32(10):2238–52.CrossRefPubMedPubMedCentral
42.
go back to reference Disney ER, Elkins IJ, McGue M, Iacono WG. Effects of ADHD, conduct disorder, and gender on substance use and abuse in adolescence. Am J Psychiatry. 1999;156(10):1515–21.CrossRefPubMed Disney ER, Elkins IJ, McGue M, Iacono WG. Effects of ADHD, conduct disorder, and gender on substance use and abuse in adolescence. Am J Psychiatry. 1999;156(10):1515–21.CrossRefPubMed
43.
go back to reference Pacek LR, Vandrey R. Cannabis use history and characteristics of quit attempts: a comparison study of treatment-seeking and non-treatment-seeking cannabis users. Exp Clin Psychopharmacol. 2014;22(6):517.CrossRefPubMedPubMedCentral Pacek LR, Vandrey R. Cannabis use history and characteristics of quit attempts: a comparison study of treatment-seeking and non-treatment-seeking cannabis users. Exp Clin Psychopharmacol. 2014;22(6):517.CrossRefPubMedPubMedCentral
44.
go back to reference Johnston LD, M P, O’Malley RA, JGB M, Schulenberg JE. Monitoring the Future: National survey results on drug use, 1975–2015: Overview: key findings on adolescent drug use. Ann Arbor: Institute for Social Research, University of Michigan; 2016. Johnston LD, M P, O’Malley RA, JGB M, Schulenberg JE. Monitoring the Future: National survey results on drug use, 1975–2015: Overview: key findings on adolescent drug use. Ann Arbor: Institute for Social Research, University of Michigan; 2016.
45.
go back to reference Conrod PJ, Nikolaou K. Annual Research Review: On the developmental neuropsychology of substance use disorders. J Child Psychol Psychiatry. 2016;57(3):371–94.CrossRefPubMed Conrod PJ, Nikolaou K. Annual Research Review: On the developmental neuropsychology of substance use disorders. J Child Psychol Psychiatry. 2016;57(3):371–94.CrossRefPubMed
46.
go back to reference Broyd SJ, van Hell HH, Beale C, Yücel M, Solowij N. Acute and chronic effects of cannabinoids on human cognition—a systematic review. Biol Psychiatry. 2016;79(7):557–67.CrossRefPubMed Broyd SJ, van Hell HH, Beale C, Yücel M, Solowij N. Acute and chronic effects of cannabinoids on human cognition—a systematic review. Biol Psychiatry. 2016;79(7):557–67.CrossRefPubMed
47.
go back to reference Lisdahl KM, Gilbart ER, Wright NE, Shollenbarger S. Dare to delay? The impacts of adolescent alcohol and marijuana use onset on cognition, brain structure, and function. Front Psychiatry. 2013;4(53). Lisdahl KM, Gilbart ER, Wright NE, Shollenbarger S. Dare to delay? The impacts of adolescent alcohol and marijuana use onset on cognition, brain structure, and function. Front Psychiatry. 2013;4(53).
48.
go back to reference Lynskey M, Hall W. The effects of adolescent cannabis use on educational attainment: a review. Addiction. 2000;95(11):1621–30.CrossRefPubMed Lynskey M, Hall W. The effects of adolescent cannabis use on educational attainment: a review. Addiction. 2000;95(11):1621–30.CrossRefPubMed
49.
go back to reference Fergusson DM, Horwood LJ, Beautrais AL. Cannabis and educational achievement. Addiction. 2003;98(12):1681–92.CrossRefPubMed Fergusson DM, Horwood LJ, Beautrais AL. Cannabis and educational achievement. Addiction. 2003;98(12):1681–92.CrossRefPubMed
50.
go back to reference Brook JS, Stimmel MA, Zhang C, Brook DW. The association between earlier marijuana use and subsequent academic achievement and health problems: a longitudinal study. Am J Addictions. 2008;17(2):155–60.CrossRef Brook JS, Stimmel MA, Zhang C, Brook DW. The association between earlier marijuana use and subsequent academic achievement and health problems: a longitudinal study. Am J Addictions. 2008;17(2):155–60.CrossRef
51.
go back to reference Van Ours JC, Williams J. Why parents worry: initiation into cannabis use by youth and their educational attainment. J Health Econ. 2009;28(1):132–42.CrossRefPubMed Van Ours JC, Williams J. Why parents worry: initiation into cannabis use by youth and their educational attainment. J Health Econ. 2009;28(1):132–42.CrossRefPubMed
52.
go back to reference Pedersen W. Cannabis use: Subcultural opposition or social marginality? A population-based longitudinal study. Acta Sociologica. 2009;52(2):135–48.CrossRef Pedersen W. Cannabis use: Subcultural opposition or social marginality? A population-based longitudinal study. Acta Sociologica. 2009;52(2):135–48.CrossRef
53.
54.
go back to reference Nagelhout, G. E., Hummel, K., de Goeij, M. C., de Vries, H., Kaner, E., & Lemmens, P. How economic recessions and unemployment affect illegal drug use: a systematic realist literature review. Int J Drug Policy. 2017 44, 69–83. Nagelhout, G. E., Hummel, K., de Goeij, M. C., de Vries, H., Kaner, E., & Lemmens, P. How economic recessions and unemployment affect illegal drug use: a systematic realist literature review. Int J Drug Policy. 2017 44, 69–83.
55.
go back to reference Teixidó-Compañó E, Espelt A, Sordo L, Bravo MJ, Sarasa-Renedo A, Indave BI, Brugal MT. Differences between men and women in substance use: the role of educational level and employment status. Gaceta Sanitaria. 2017;32(1):41–7.CrossRefPubMed Teixidó-Compañó E, Espelt A, Sordo L, Bravo MJ, Sarasa-Renedo A, Indave BI, Brugal MT. Differences between men and women in substance use: the role of educational level and employment status. Gaceta Sanitaria. 2017;32(1):41–7.CrossRefPubMed
56.
go back to reference Williams RJ, Chang SY. A comprehensive and comparative review of adolescent substance abuse treatment outcome. Clin Psychol. 2000;7(2):138–66. Williams RJ, Chang SY. A comprehensive and comparative review of adolescent substance abuse treatment outcome. Clin Psychol. 2000;7(2):138–66.
Metadata
Title
Who seeks treatment for cannabis use? Registered characteristics and physical, psychological and psychosocial problem indicators among cannabis patients and matched controls
Authors
Solveig Glestad Christiansen
Anne Line Bretteville-Jensen
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2018
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-018-5625-0

Other articles of this Issue 1/2018

BMC Public Health 1/2018 Go to the issue